erythromycin

Generic: erythromycin

Labeler: teva pharmaceuticals usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name erythromycin
Generic Name erythromycin
Labeler teva pharmaceuticals usa, inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

erythromycin 250 mg/1

Manufacturer
Teva Pharmaceuticals USA, Inc.

Identifiers & Regulatory

Product NDC 0093-5571
Product ID 0093-5571_f750327c-00a6-48d0-9a87-b5b0af53a3c3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214549
Listing Expiration 2026-12-31
Marketing Start 2021-05-04

Pharmacologic Class

Established (EPC)
macrolide [epc] macrolide antimicrobial [epc]
Chemical Structure
macrolides [cs]
Physiologic Effect
decreased sebaceous gland activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00935571
Hyphenated Format 0093-5571

Supplemental Identifiers

RxCUI
197650 598006
UPC
0300935572567
UNII
63937KV33D
NUI
N0000009982 N0000175877 N0000175935 M0028311

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name erythromycin (source: ndc)
Generic Name erythromycin (source: ndc)
Application Number ANDA214549 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 100 TABLET, FILM COATED in 1 BOTTLE (0093-5571-01)
  • 30 TABLET, FILM COATED in 1 BOTTLE (0093-5571-56)
source: ndc

Packages (2)

Ingredients (1)

erythromycin (250 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f750327c-00a6-48d0-9a87-b5b0af53a3c3", "openfda": {"nui": ["N0000009982", "N0000175877", "N0000175935", "M0028311"], "upc": ["0300935572567"], "unii": ["63937KV33D"], "rxcui": ["197650", "598006"], "spl_set_id": ["75a0bd5a-d09f-483b-bfd8-f8343b149eb2"], "pharm_class_cs": ["Macrolides [CS]"], "pharm_class_pe": ["Decreased Sebaceous Gland Activity [PE]"], "pharm_class_epc": ["Macrolide [EPC]", "Macrolide Antimicrobial [EPC]"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (0093-5571-01)", "package_ndc": "0093-5571-01", "marketing_start_date": "20210504"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0093-5571-56)", "package_ndc": "0093-5571-56", "marketing_start_date": "20210504"}], "brand_name": "Erythromycin", "product_id": "0093-5571_f750327c-00a6-48d0-9a87-b5b0af53a3c3", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Macrolide Antimicrobial [EPC]", "Macrolide [EPC]", "Macrolides [CS]"], "product_ndc": "0093-5571", "generic_name": "Erythromycin", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Erythromycin", "active_ingredients": [{"name": "ERYTHROMYCIN", "strength": "250 mg/1"}], "application_number": "ANDA214549", "marketing_category": "ANDA", "marketing_start_date": "20210504", "listing_expiration_date": "20261231"}